These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
587 related items for PubMed ID: 8828497
21. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Fowlkes JL, Thrailkill KM, George-Nascimento C, Rosenberg CK, Serra DM. Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012 [Abstract] [Full Text] [Related]
22. Metabolism of endothelial cell-bound lipoprotein lipase. Evidence for heparan sulfate proteoglycan-mediated internalization and recycling. Saxena U, Klein MG, Goldberg IJ. J Biol Chem; 1990 Aug 05; 265(22):12880-6. PubMed ID: 2142941 [Abstract] [Full Text] [Related]
23. Insulin-like growth factor-binding protein-3 (IGFBP-3) concentration in rat Sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans. Smith EP, Lu L, Chernausek SD, Klein DJ. Endocrinology; 1994 Jul 05; 135(1):359-64. PubMed ID: 7516869 [Abstract] [Full Text] [Related]
24. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. Benitz WE, Kelley RT, Anderson CM, Lorant DE, Bernfield M. Am J Respir Cell Mol Biol; 1990 Jan 05; 2(1):13-24. PubMed ID: 2137707 [Abstract] [Full Text] [Related]
25. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs. Lee CY, Rechler MM. Endocrinology; 1995 Nov 05; 136(11):4982-9. PubMed ID: 7588232 [Abstract] [Full Text] [Related]
26. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. Fowlkes JL, Serra DM, Rosenberg CK, Thrailkill KM. J Biol Chem; 1995 Nov 17; 270(46):27481-8. PubMed ID: 7499205 [Abstract] [Full Text] [Related]
27. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. Conover CA, Khosla S. Growth Horm IGF Res; 2003 Dec 17; 13(6):328-35. PubMed ID: 14624766 [Abstract] [Full Text] [Related]
28. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Hallak LK, Collins PL, Knudson W, Peeples ME. Virology; 2000 Jun 05; 271(2):264-75. PubMed ID: 10860881 [Abstract] [Full Text] [Related]
29. Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation. Cisar LA, Hoogewerf AJ, Cupp M, Rapport CA, Bensadoun A. J Biol Chem; 1989 Jan 25; 264(3):1767-74. PubMed ID: 2521485 [Abstract] [Full Text] [Related]
30. The critical interaction of the metallopeptidase PHEX with heparan sulfate proteoglycans. Barros NM, Nascimento FD, Oliveira V, Juliano MA, Juliano L, Loisel T, Nader HB, Boileau G, Tersariol IL, Carmona AK. Int J Biochem Cell Biol; 2008 Jan 25; 40(12):2781-92. PubMed ID: 18585473 [Abstract] [Full Text] [Related]
31. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction. Salahifar H, Baxter RC, Martin JL. Endocrinology; 1997 Apr 25; 138(4):1683-90. PubMed ID: 9075731 [Abstract] [Full Text] [Related]
32. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. Conover CA. Endocrinology; 1991 Dec 25; 129(6):3259-68. PubMed ID: 1720092 [Abstract] [Full Text] [Related]
33. Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor. Reich-Slotky R, Bonneh-Barkay D, Shaoul E, Bluma B, Svahn CM, Ron D. J Biol Chem; 1994 Dec 23; 269(51):32279-85. PubMed ID: 7528211 [Abstract] [Full Text] [Related]
34. Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro. Møller AV, Jørgensen SP, Chen JW, Larnkjaer A, Ledet T, Flyvbjerg A, Frystyk J. Eur J Endocrinol; 2006 Aug 23; 155(2):297-305. PubMed ID: 16868144 [Abstract] [Full Text] [Related]
35. The malaria circumsporozoite protein: interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate. Ying P, Shakibaei M, Patankar MS, Clavijo P, Beavis RC, Clark GF, Frevert U. Exp Parasitol; 1997 Feb 23; 85(2):168-82. PubMed ID: 9030667 [Abstract] [Full Text] [Related]
36. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Lalou C, Lassarre C, Binoux M. Endocrinology; 1996 Aug 23; 137(8):3206-12. PubMed ID: 8754741 [Abstract] [Full Text] [Related]
37. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan. Engbring JA, Hoffman MP, Karmand AJ, Kleinman HK. Cancer Res; 2002 Jun 15; 62(12):3549-54. PubMed ID: 12068003 [Abstract] [Full Text] [Related]